They're definitely trying to capture the whole MPB market share and they will succeed. I am super stoked.
Where are the phase IIb results for Bimatoprost?
Collapse
X
-
-
I think everyone is curious what using those 2 drugs in combination would do. What kind of results are we talking? Could be minor or huge really impossible to guess. It would be kind of funny to see MPB nearly cured with a combo like this that no one would ever predicted or expected. For all the talk everyone does about millions of things about diet, air pollution, and so on causing MPB it would be odd for something like this to grow back a lot of hair. I guess lots of people turning out to be wrong is not a new thing either.Comment
-
I think everyone is curious what using those 2 drugs in combination would do. What kind of results are we talking? Could be minor or huge really impossible to guess. It would be kind of funny to see MPB nearly cured with a combo like this that no one would ever predicted or expected. For all the talk everyone does about millions of things about diet, air pollution, and so on causing MPB it would be odd for something like this to grow back a lot of hair. I guess lots of people turning out to be wrong is not a new thing either.Comment
-
" The true Holy Grail may come from combining a drug like Latisse with a certain type of medication commonly used to treat allergies and asthma. The medication blocks a hormone-like substance that prevents hair from growing. A treatment like this might help with hair growth. Using these drugs in combination is like taking your foot off-break and stepping on gas at the same time."
Comment
-
So I guess the Investor Relations woman was right. Why else would Allergan buy $KYTH if they didn't want to use Seti in conjunction with Bim? To whomever said Bim's Phase II had negative results... what now?!Comment
-
Allergan is buying Kythera for $2.1 billion. I find this very interesting, given that Kythera's Chief Medical Officer worked at Allergan for over a decade. Also, they announced trials for Setipiprant soon after the phase IIb studies for bimatoprost were complete for Allergan. I'm sure they knew the results, given the company ties. This is very interesting given the mutual reliance on prostaglandin science.
It looks like Allergan may be trying to corner the hair loss market. Look at this quote in April 2014 from Bosley Medical Director, Ken Washenik:
" The true Holy Grail may come from combining a drug like Latisse with a certain type of medication commonly used to treat allergies and asthma. The medication blocks a hormone-like substance that prevents hair from growing. A treatment like this might help with hair growth. Using these drugs in combination is like taking your foot off-break and stepping on gas at the same time."
Looks like Allergan is trying to corner the hair loss market. Sure, nobody wants a double chin either, but if Setipiprant is successful, it would shatter any earnings made by that injectable fat-burning drug. I really hope this means bim was successful, it may mean just that.
but they can't make a combination of these two.
something big may be brewing behind the scenes here, and neither of these products are too far in the distance.Comment
-
-
New to this topic - what is the working principle behind Bimatoprost? Is it another DHT blocker?Comment
-
Not saying Allergan isn't interested in Seti, but it's not Kythera's only product.Comment
-
Comment
-
Hopefully, and likely. There is a provision in the bill that speeds up development for repurposed drugs. AND guess what? The majority of Congress (of both dems and repubs) just cosponsored the bill, meaning it will surely make it through Congress.
http://energycommerce.house.gov/pres...igns-cures2015. Nothing compared like a few years ago with all these 'breaktrough mice studies' haha
Comment
-
Omg that's great! New generation treatments are really not far away from us. Everything goes in the good way ( 21st century cure, competition between companies,etc..). Even the more pessimists guys begin to change their mind I'm sure. Nothing compared like a few years ago with all these 'breaktrough mice studies' haha
Comment
Comment